<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Dr. Eric Ouellet | Senior Scientist</title>
  <meta name="description" content="Dr. Eric Ouellet, Senior Scientist at STEMCELL Technologies, specializing in non-viral intracellular delivery, gene editing, and microfluidics innovation.">
  <link rel="stylesheet" href="style.css">

  <!-- JSON-LD Schema for Knowledge Graph -->
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "Person",
    "name": "Dr. Eric Ouellet",
    "alternateName": "Eric Ouellet",
    "jobTitle": "Senior Scientist",
    "worksFor": {
      "@type": "Organization",
      "name": "STEMCELL Technologies",
      "url": "https://www.stemcell.com"
    },
    "url": "https://ericouellet.github.io",
    "sameAs": [
      "https://www.linkedin.com/in/eric-ouellet",
      "https://orcid.org/0000-0000-0000-0000",
      "https://scholar.google.com/citations?user=XXXXXXX"
    ],
    "image": "assets/photo.jpg",
    "description": "Senior Scientist at STEMCELL Technologies specializing in non-viral intracellular delivery, gene editing, and microfluidics innovation."
  }
  </script>
</head>
<body>
  <div class="container">
    <header>
      <h1>Dr. Eric Ouellet</h1>
      <p>Senior Scientist | Non-Viral Intracellular Delivery</p>
    </header>

    <main class="profile">
      <div class="about">
        <h2>About Me</h2>
        <p>Dr. Eric Ouellet is a Senior Scientist at STEMCELL Technologies, specializing in non-viral intracellular delivery of nucleic acids and proteins into hard-to-transfect primary human cells. He led the development of the <strong>CellPoreâ„¢ Transfection System</strong>, a next-generation microfluidic platform enabling high-efficiency delivery into immune and stem cells.</p>
        <p>His work bridges engineering and life sciences, focusing on mechanoporation, electroporation, and lipid-based transfection. Dr. Ouellet has extensive experience with gene editing in T cells, NK cells, B cells, CD34+ hematopoietic stem and progenitor cells, and human pluripotent stem cells.</p>
        <p>He also contributes to platform-agnostic product pipelines, aptamer development, and microfluidics innovation for intracellular delivery technologies.</p>
      </div>

      <div class="details">
        <img src="assets/photo.jpg" alt="Dr. Eric Ouellet" class="profile-photo">
        <ul>
          <li><strong>Name:</strong> Dr. Eric Ouellet</li>
          <li><strong>Title:</strong> Senior Scientist</li>
          <li><strong>Organization:</strong> STEMCELL Technologies</li>
        </ul>
        <div class="links">
          <a href="https://www.linkedin.com/in/eric-ouellet">LinkedIn</a>
          <a href="https://orcid.org/0000-0000-0000-0000">ORCID</a>
          <a href="https://scholar.google.com/citations?user=XXXXXXX">Google Scholar</a>
        </div>
      </div>
    </main>
  </div>
</body>
</html>
